Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A. Marzinke, Susan H. Eshleman, Ryan Kofron et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 30
Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spotsEthel D. Weld, Mark A. Marzinke, Teresa L. Parsons et al.|Journal of Pharmaceutical and Biomedical Analysis|2023Cited by 10